The Pakistan-China Pharmaceutical and Healthcare B2B Investment Conference will commence in Islamabad from 17th of this month.

The two-day event is being organized through the joint efforts of the Special Investment Facilitation Council (SIFC), the Ministry of National Health Services, and the Drug Regulatory Authority of Pakistan.

The conference aims to promote investment and industrial cooperation in the pharmaceutical, healthcare and biotechnology sectors.

It is expected to strengthen Pakistan-China collaboration by encouraging investment, technology transfer, and industrial partnerships in the pharmaceutical and healthcare sectors.

The conference will feature business-to-business (B2B) meetings, networking opportunities and dedicated investment sessions to facilitate engagement between companies from both countries.

The conference is also expected to contribute to the modernization of Pakistan's healthcare system and enhance the competitiveness of the country's pharmaceutical industry.

Supported by the SIFC, Pakistan's healthcare and pharmaceutical sectors are opening up new opportunities for advanced technology, investment and industrial collaboration.